Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Starrett

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Cell Host & Microbe|May 11, 2018
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus EvolutionAlberto Peretti, Eileen M Geoghegan, Diana V Pastrana, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2013
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic painYong-Jin Wu, Charles M Conway, Li-Qiang Sun, et al.
Genome Announcements|March 22, 2013
Complete Genome of Serratia sp. Strain FGI 94, a Strain Associated with Leaf-Cutter Ant Fungus GardensFrank O Aylward, Daniel M Tremmel, Gabriel J Starrett, et al.
Journal of Medicinal Chemistry|July 11, 2003
(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraineYong-Jin Wu, Christopher G Boissard, Corinne Greco, et al.
Plos Genetics|May 10, 2006
Chemical genetics reveals an RGS/G-protein role in the action of a compoundKevin Fitzgerald, Svetlana Tertyshnikova, Lisa Moore, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Cancer Research|March 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> MutationsJacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo, et al.
The New England Journal of Medicine|September 1, 2021
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer CellsAndrea Lisco, Amy P Hsu, Dimana Dimitrova, et al.
The Journal of Clinical Investigation|December 15, 2025
Interlocking host and viral cis-regulatory networks drive Merkel cell carcinomaLingling Miao, David Milewski, Amy Coxon, et al.
Elife|February 5, 2020
Discovery of several thousand highly diverse circular DNA virusesMichael J Tisza, Diana V Pastrana, Nicole L Welch, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Cell Host & Microbe|May 11, 2018
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus EvolutionAlberto Peretti, Eileen M Geoghegan, Diana V Pastrana, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2013
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic painYong-Jin Wu, Charles M Conway, Li-Qiang Sun, et al.
Genome Announcements|March 22, 2013
Complete Genome of Serratia sp. Strain FGI 94, a Strain Associated with Leaf-Cutter Ant Fungus GardensFrank O Aylward, Daniel M Tremmel, Gabriel J Starrett, et al.
Journal of Medicinal Chemistry|July 11, 2003
(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraineYong-Jin Wu, Christopher G Boissard, Corinne Greco, et al.
Plos Genetics|May 10, 2006
Chemical genetics reveals an RGS/G-protein role in the action of a compoundKevin Fitzgerald, Svetlana Tertyshnikova, Lisa Moore, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Cancer Research|March 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> MutationsJacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo, et al.
The New England Journal of Medicine|September 1, 2021
Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer CellsAndrea Lisco, Amy P Hsu, Dimana Dimitrova, et al.
The Journal of Clinical Investigation|December 15, 2025
Interlocking host and viral cis-regulatory networks drive Merkel cell carcinomaLingling Miao, David Milewski, Amy Coxon, et al.
Elife|February 5, 2020
Discovery of several thousand highly diverse circular DNA virusesMichael J Tisza, Diana V Pastrana, Nicole L Welch, et al.
Pageof 30